Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (KRYS) (the “Company”) (NASDAQ: KRYS) announced today that the United States Food and Drug Administration (FDA) granted platform ...

Two kernels, 100 years apart: One yielded 60 bushels per acre in 1927; the other topped 623. They look nearly identical on the outside, but a century of genetic innovation separates them under the ...

Biotech has long been one of the strongest sector stories of the past year, and investors who got there early have been rewarded. As of April 2, 2026, the State Street SPDR S&P Biotech ETF (NYSE:XBI) ...

Trinity Biotech plc announced a significant step in its transformation plan by appointing Barclays Capital Inc. as its exclusive financial advisor. The company is shifting its focus to developing its ...

Bernhard running samples at the DARO lab at the BioTech Connector on the Nebraska Innovation Campus. Photo provided by DARO. DARO, a biotech startup in Lincoln centered around early disease detection ...

The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is trading at three year highs despite market volatility, responding to breakthrough innovations and increased deals involving NASDAQ biotech stocks.

Global pharmaceutical and biotech companies are opening their wallets to secure Chinese new drug candidates. As China has ...

MARTINSRIED, Germany--(BUSINESS WIRE)--SIRION Biotech GmbH announced today that Beam Therapeutics licensed rights to use SIRION Biotech’s LentiBOOST™ for use in their CAR-T cell products. CAR-T cell ...

A Frederick biotech company will unveil a new technology allowing cellular-level observation of tumors at a conference in Philadelphia next week. Nanocrine, based in the headquarters for the Frederick ...

The American Seed Trade Association will be the lead advocate for crop biotechnology now that the Biotechnology Innovation Organization has eliminated its agriculture and environment section. ASTA was ...

Regarding market potential, I see it following an exponential curve, with forecasts indicating that by 2030, gene therapies and genetic corrections will become more widely available, potentially ...